Nothing Special   »   [go: up one dir, main page]

Bergen, 2007 - Google Patents

Characterization and recognition of minor histocompatibility antigens

Bergen, 2007

View PDF
Document ID
10554760732993004953
Author
Bergen K
Publication year
Publication venue
Blood

External Links

Snippet

Minor histocompatibility antigens (MiHA) play an important role in both graft-versus-tumor effects and graft-versus-host disease (GvHD) after allogeneic stem cell transplantation. We applied biochemical techniques and mass spectrometry to identify the peptide recognized …
Continue reading at scholarlypublications.universiteitleiden.nl (PDF) (other versions)

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues ; Not used, see subgroups
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0636—T lymphocytes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology

Similar Documents

Publication Publication Date Title
van Bergen et al. Multiple myeloma–reactive T cells recognize an activation-induced minor histocompatibility antigen encoded by the ATP-dependent interferon-responsive (ADIR) gene
EP3383892B1 (en) Modified chimeric receptors and related compositions and methods
CN108026512B (en) Modified natural killer cells and natural killer cell lines with enhanced cytotoxicity
CN110330567B (en) Bispecific chimeric antigen receptor T cells, methods of making and uses thereof
EP3227323B1 (en) Methods and compositions for adoptive cell therapy
EP3399985B1 (en) Compositions and libraries comprising recombinant t-cell receptors and methods of using recombinant t-cell receptors
KR20190064566A (en) The anti-KRAS-G12D T cell receptor
CN110462024B (en) MR 1-restricted T cell receptor for cancer immunotherapy
CN115073583A (en) T cell receptor recognizing HLA-CW8 restriction mutant KRAS
CA2777821A1 (en) Tumor-associated peptides that bind to mhc-molecules
Griffioen et al. Identification of 4 novel HLA-B* 40: 01 restricted minor histocompatibility antigens and their potential as targets for graft-versus-leukemia reactivity
CN113631172A (en) Compositions and methods for targeting mutant RAS
EP3645560B1 (en) Treatment of haematological malignancies
CN113621047A (en) T cell antigen receptor, polymer compound thereof, preparation method and application thereof
CN112673018A (en) MR 1-restricted T cell receptor for cancer immunotherapy
EP4253410A1 (en) Ras mutant epitope peptide and t cell receptor recognizing ras mutant
JP2004535779A (en) Tumor peptide antigen produced from human MDM2 proto-oncogene
EP0876397B1 (en) Tumor rejection antigens presented by hla-b44 molecules, and uses thereof
CN113195526A (en) Targeting mutant MYD88 in adoptive T cell therapyL265PSpecific T cell receptors for protein epitopes
Bergen Characterization and recognition of minor histocompatibility antigens
Wölfel et al. Dissection and molecular analysis of alloreactive CD8+ T cell responses in allogeneic haematopoietic stem cell transplantation
Ivanov et al. UTY‐specific TCR‐transfer generates potential graft‐versus‐leukaemia effector T cells
JP2023526416A (en) T cell receptor with VGLL1 specificity and methods of use thereof
WO2023219510A1 (en) Treatment of haematological malignancies
US12139526B2 (en) Modified chimeric receptors and related compositions and methods